Key Takeaways
- Johnson & Johnson is investing more than $1 billion in Jacksonville, Florida, to expand U.S.-based manufacturing, packaging and distribution capabilities for its Acuvue contact lens business
- The project includes a new state-of-the-art distribution facility and advanced manufacturing technologies designed to increase production capacity and meet global demand for Acuvue contact lenses, with operations expected to be fully online by 2028
Johnson & Johnson announced plans to invest more than $1 billion in its vision business operations in Jacksonville, Florida, a move aimed at expanding US-based manufacturing, packaging and distribution capabilities for its Acuvue contact lens portfolio.
The investment will fund construction of a new distribution facility and deployment of advanced manufacturing and packaging technologies designed to increase production capacity and support growing global demand for Acuvue contact lenses. The company said the expansion will further strengthen its ability to deliver eye health products to more than 40 million patients worldwide.
“This investment reinforces our long-standing conviction that advanced manufacturing in the United States is essential to delivering innovative, high-quality healthcare solutions to patients at home and around the world,” said Joaquin Duato, chairman and chief executive officer of Johnson & Johnson. “By further strengthening our Vision operations in Jacksonville with next-generation manufacturing, packaging and distribution capabilities, we are enhancing the resilience of our U.S. supply chain while helping more people see better and live better.”
The Jacksonville investment is part of Johnson & Johnson’s previously announced $55 billion commitment to US manufacturing, research and development, and technology through early 2029. Construction is already underway, with the new facility expected to become fully operational in 2028.
Johnson & Johnson Vision has maintained a presence in Jacksonville since 1981 and today operates more than 1.5 million square feet of manufacturing, research, distribution and operations facilities in the region. The company currently manufactures more than 1.7 billion Acuvue contact lenses annually for the US market from its Jacksonville operations. The latest investment is expected to support continued growth of the Jacksonville campus while strengthening opportunities for the approximately 3,500 employees working in the area.
Johnson & Johnson said the Jacksonville project will enhance its ability to scale manufacturing and distribution operations while maintaining quality standards across its Acuvue portfolio. The company noted that the investment reflects its broader strategy of strengthening domestic manufacturing capabilities while supporting innovation in eye health.
